Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves’ Disease

American Journal of Pathology

Volumn 161, Issue 1, 2002, Pages 195-206

  Romagnani, Paola ^a   Rotondi, Mario ^b   Lazzeri, Elena ^a   Lasagni, Laura ^a   Francalanci, Michela ^a   Buonamano, Andrea ^a   Milani, Stefano ^a   Vitti, Paolo ^c   Chiovato, Luca ^c   Tonacchera, Massimo ^c   Bellastella, Antonio ^b   Serio, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GRAVES DISEASE; HELPER CELL; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; THYROID FOLLICLE CELL; THYROID GLAND; THYROID TUMOR; THYROIDECTOMY;

EID: 0036317941     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64171-5     Document Type: Article

References (38)

1. Graves’ disease
2. Determinants of autoimmune thyroid disease
3. Autoimmune disease: Why and where it occurs
4. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors
5. The biology of chemokines and their receptors
6. Chemokines: A new classification system and their role in immunity
7. Chemokine receptor specific for IP-10 and Mig: Structure, function and expression in activated T-lymphocytes
8. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
9. Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, TCRgammadelta+ T cells, and natural killer-type cells in human thymus
10. Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells
11. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment
12. Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: An amplification circuit of polarized T helper 2 responses
13. Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: Preferential association with the production of type 2 cytokines
14. Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E
15. Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome
16. Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis
17. Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy
18. T helper subsets in human disease states
19. Functional diversity of helper T lymphocytes
20. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
21. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo
22. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
23. CCR5 is characteristic of Th1 lymphocytes
24. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells
25. The autoimmune infiltrate of Basedow’s disease: Analysis of clonal level and comparison with Hashimoto’s thyroiditis
26. Lymphokine production by human T cells in disease states
27. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins
28. Relationship between disease duration and predominant orbital T cell subset in Graves’ disease
29. A one-tube polymerase chain reaction protocol demonstrates CC chemokine overexpression in Graves’ disease glands
30. Expression and regulation of regulated on activation, normal T cells expressed and secreted in thyroid tissue of patients with Graves’ disease and thyroid autonomy and in thyroid-derived cell populations
31. Reduced expression of stromal-derived factor 1 in autonomous thyroid adenomas and its regulation in thyroid-derived cells
32. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes
33. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity
34. Papillary carcinoma of the thyroid: Hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells
35. Donor-derived IP-10 initiates development of acute allograft rejection
36. IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and their regulation by nitric oxide
37. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease
38. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells